News

Johnson & Johnson MedTech announced the completion of the acquisition of Laminar, Inc., a privately-held medical device company focused on eliminating the left atrial appendage (LAA) in patients with non-valvular atrial fibrillation (AFib).

LEXINGTON, Ky. and ST. LOUIS, Nov. 28, 2023-- Stereotaxis, a pioneer in surgical robotics for minimally invasive endovascular intervention, and Baptist Health Lexington, a leading health provider in Kentucky, today announced that...

Sophia Antipolis – 21 November 2023:  The first clinical trial to challenge the routine implantation of a defibrillator in myocardial infarction survivors with heart failure has enrolled its first patient. The PROFID EHRA trial is part...

FORT MILL, SC / November 20, 2023 / Catheter Precision, Inc. (the "Company") (NYSE American:VTAK), a pioneering medical technology firm headquartered in the United States, specializing in electrophysiology devices, has proudly disclosed the...

Manufacturing of the device for U.S. distribution is already underway, and Medtronic hopes to make it widely available soon to physicians and healthcare systems.

Simplicity, efficiency, efficacy with unmatched safety data to set a new standard in catheter ablation

Strongly positive findings demonstrate the life-saving potential of the Jewel® Patch Wearable Cardioverter Defibrillator for patients at elevated risk of sudden cardiac arrest.

CHICAGO -- An oral presentation at the American Heart Association’s Scientific Sessions examined recent reporting rates of esophageal injury after left atrial ablation for the treatment of atrial fibrillation and found that the rates have not...

Secondary Endpoints Also Showed a Highly Significant 74% Reduction in Major Bleeding and a 93% Reduction in Gastrointestinal (GI) Bleeding with Abelacimab These Results Triggered the Data Monitoring Committee (DMC) to Stop the AZALEA-TIMI...